These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18798134)

  • 1. [Fabry disease - complex clinical picture, simple diagnosis procedure, causal treatment].
    Hoffmann B; Beck M; Rolfs A; Neumann HP
    Dtsch Med Wochenschr; 2008 Sep; 133(39):1965-72; quiz 1973-4. PubMed ID: 18798134
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fabry disease].
    Jakubowska E; Ryba M; Hruby Z
    Przegl Lek; 2006; 63(4):218-9. PubMed ID: 17080745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabry disease.
    Tarabuso AL
    Skinmed; 2011; 9(3):173-7. PubMed ID: 21675497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anderson--Fabry disease.
    Pyeritz RE; Bender WL; Lipford EH
    Johns Hopkins Med J; 1982 May; 150(5):181-7. PubMed ID: 6281510
    [No Abstract]   [Full Text] [Related]  

  • 5. Fabry disease.
    Schiffmann R
    Pharmacol Ther; 2009 Apr; 122(1):65-77. PubMed ID: 19318041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent therapeutics for Fabry disease].
    Etou Y
    Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):875-82. PubMed ID: 19469078
    [No Abstract]   [Full Text] [Related]  

  • 7. An unusual cause of dyspnea.
    Jamali AH; Ahmed RM; Stein H
    Cardiol Rev; 2004; 12(1):10-4. PubMed ID: 14667257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fabry disease: Pathogenesis, pathophysiology, and therapy].
    Utsumi K
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():537-40. PubMed ID: 16523950
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fabry disease in cardiology: Diagnosis and therapeutic approaches].
    Çavuşoğlu Y; Özpelit E; Arslan N; Demir M; Kahveci G; Onay H; Ökçün EÖB; Tufekcioglu O; Tülüce SY; Yıldırım GK
    Turk Kardiyol Dern Ars; 2020 Dec; 48(Suppl 2):1-42. PubMed ID: 33476309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural history and treatment of renal involvement in Fabry disease.
    Branton M; Schiffmann R; Kopp JB
    J Am Soc Nephrol; 2002 Jun; 13 Suppl 2():S139-43. PubMed ID: 12068026
    [No Abstract]   [Full Text] [Related]  

  • 11. Fabry disease in childhood.
    Desnick RJ; Brady RO
    J Pediatr; 2004 May; 144(5 Suppl):S20-6. PubMed ID: 15126980
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal pathology in Fabry disease.
    Alroy J; Sabnis S; Kopp JB
    J Am Soc Nephrol; 2002 Jun; 13 Suppl 2():S134-8. PubMed ID: 12068025
    [No Abstract]   [Full Text] [Related]  

  • 13. Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults.
    Ortiz A; Oliveira JP; Wanner C; Brenner BM; Waldek S; Warnock DG
    Nat Clin Pract Nephrol; 2008 Jun; 4(6):327-36. PubMed ID: 18431378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy.
    Thurberg BL; Fallon JT; Mitchell R; Aretz T; Gordon RE; O'Callaghan MW
    Circulation; 2009 May; 119(19):2561-7. PubMed ID: 19414635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapies for Fabry's disease.
    Gahl WA
    N Engl J Med; 2001 Jul; 345(1):55-7. PubMed ID: 11439950
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of recombinant alpha-galactosidase A therapy for amelioration of the cardiovascular manifestations of Fabry disease: an important role for endomyocardial biopsy.
    Buja LM
    Circulation; 2009 May; 119(19):2539-41. PubMed ID: 19451361
    [No Abstract]   [Full Text] [Related]  

  • 17. Guidelines to diagnosis and monitoring of Fabry disease and review of treatment experiences.
    Martins AM; D'Almeida V; Kyosen SO; Takata ET; Delgado AG; Gonçalves AM; Benetti Filho CC; Martini Filho D; Biagini G; Pimentel H; Abensur H; Guimarães HC; Gomes JG; Sobral Neto J; D'Almeida LO; Carvalho LR; Harouche MB; Maldonado MC; Nascimento OJ; Montoril PS; Bastos RV
    J Pediatr; 2009 Oct; 155(4 Suppl):S19-31. PubMed ID: 19765408
    [No Abstract]   [Full Text] [Related]  

  • 18. An easy and sensitive method for determination of globotriaosylceramide (Gb3) from urinary sediment: utility for Fabry disease diagnosis and treatment monitoring.
    Rozenfeld PA; De Francesco NP; Borrajo GJ; Ceci R; Fossati CA
    Clin Chim Acta; 2009 May; 403(1-2):194-7. PubMed ID: 19268437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic analysis of Fabry disease: report of six cases including three heterozygous females.
    Nagasaki A; Nishie W; Sato K; Oba I; Noguchi E; Akitsu H; Sawamura D; Shimizu H
    J Dermatol Sci; 2008 Oct; 52(1):61-4. PubMed ID: 18555667
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fabry disease (alpha-galactosidase deficiency)].
    Utsumi K; Sakuraba H
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):367-71. PubMed ID: 9645084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.